Sean Cassidy - Arvinas CFO

ARVN Stock  USD 31.77  0.13  0.41%   

CFO

Mr. Sean A. Cassidy CPA is Chief Financial Officer of the company. He has served as our Chief Financial Officer since July 2013. Prior to joining Arvinas, Mr. Cassidy served as the Chief Financial Officer of Axerion Therapeutics, Inc., a biotechnology company, from June 2010 to June 2013. He was also the Chief Financial Officer of Curagen Corporationrationration, a biopharmaceutical company, from January 2008 to December 2009. Mr. Cassidy is a certified public accountant and began his career at Deloitte and Touche LLP since 2013.
Age 48
Tenure 11 years
Professional MarksMBA
Address 5 Science Park, New Haven, CT, United States, 06511
Phone203 535 1456
Webhttps://www.arvinas.com
Cassidy holds an M.B.A and a B.S. in Accounting from the University of Connecticut.

Arvinas Management Efficiency

The company has return on total asset (ROA) of (0.195) % which means that it has lost $0.195 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5997) %, meaning that it created substantial loss on money invested by shareholders. Arvinas' management efficiency ratios could be used to measure how well Arvinas manages its routine affairs as well as how well it operates its assets and liabilities. As of the 1st of May 2024, Return On Tangible Assets is likely to drop to -0.3. In addition to that, Return On Capital Employed is likely to drop to -0.4. At this time, Arvinas' Non Currrent Assets Other are very stable compared to the past year. As of the 1st of May 2024, Other Current Assets is likely to grow to about 8.4 M, while Total Assets are likely to drop about 753.2 M.
The company currently holds 3.4 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Arvinas has a current ratio of 5.22, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Arvinas until it has trouble settling it off, either with new capital or with free cash flow. So, Arvinas' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Arvinas sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Arvinas to invest in growth at high rates of return. When we think about Arvinas' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 8 records

CFO Age

Peter GriffithAmgen Inc
65
David MelineAmgen Inc
61
CPA IIAir Lease
45
Steven FielerHP Inc
44
John RaineyWalmart
53
Steve FielerHP Inc
44
Patricia YarringtonChevron Corp
60
Catherine LesjakHP Inc
58
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas, Inc. was founded in 2013 and is based in New Haven, Connecticut. Arvinas operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 280 people. Arvinas (ARVN) is traded on NASDAQ Exchange in USA. It is located in 5 Science Park, New Haven, CT, United States, 06511 and employs 445 people. Arvinas is listed under Pharmaceuticals category by Fama And French industry classification.

Management Performance

Arvinas Leadership Team

Elected by the shareholders, the Arvinas' board of directors comprises two types of representatives: Arvinas inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Arvinas. The board's role is to monitor Arvinas' management team and ensure that shareholders' interests are well served. Arvinas' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Arvinas' outside directors are responsible for providing unbiased perspectives on the board's policies.
David Santos, CFO, Vice President - Business Development
Leslie Norwalk, Director
John Grosso, Senior Operations
Randy Teel, Senior Development
John Houston, President CEO, Director
Edward Kennedy, Independent Director
Jakob Loven, Independent Director
Ronald MD, Chief Officer
Steve Weiss, Senior Officer
Oto Cavalcante, Chairman of the Board
Ronald Peck, Chief Medical Officer
Bradley Margus, Independent Director
Angela Cacace, Senior Biology
Sean Cassidy, CFO
Jared JD, General Secretary
Timothy Shannon, Independent Chairman of the Board
Briggs Morrison, Independent Director
David MBA, Principal VP
Andrew Crew, CTO
Alberto Menache, Independent Director
CPA CPA, CFO Treasurer
Ian Taylor, Chief Scientific Officer
Liam Ratcliffe, Independent Director
Matthew JD, Gen Sec
Martin Escobari, Independent Director
Lisa Sinclair, Senior Operations
John Northcott, Chief Officer
Ari Neto, CEO, Director
Joao Silva, COO
Kush Parmar, Independent Director
Jeff Boyle, Vice Relations

Arvinas Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Arvinas a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Arvinas Investors Sentiment

The influence of Arvinas' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Arvinas. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Arvinas' public news can be used to forecast risks associated with an investment in Arvinas. The trend in average sentiment can be used to explain how an investor holding Arvinas can time the market purely based on public headlines and social activities around Arvinas. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Arvinas' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Arvinas' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Arvinas' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Arvinas.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Arvinas in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Arvinas' short interest history, or implied volatility extrapolated from Arvinas options trading.

Pair Trading with Arvinas

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Arvinas position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arvinas will appreciate offsetting losses from the drop in the long position's value.

Moving against Arvinas Stock

  0.8MMM 3M Company Buyout TrendPairCorr
  0.78CGC Canopy Growth Corp TrendingPairCorr
  0.73GE GE Aerospace Earnings Call This WeekPairCorr
  0.66CVX Chevron Corp Financial Report 26th of July 2024 PairCorr
  0.64BAC Bank of America Financial Report 16th of July 2024 PairCorr
The ability to find closely correlated positions to Arvinas could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Arvinas when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Arvinas - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Arvinas to buy it.
The correlation of Arvinas is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Arvinas moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Arvinas moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Arvinas can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Arvinas offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arvinas' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arvinas Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arvinas Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arvinas. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for Arvinas Stock analysis

When running Arvinas' price analysis, check to measure Arvinas' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arvinas is operating at the current time. Most of Arvinas' value examination focuses on studying past and present price action to predict the probability of Arvinas' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arvinas' price. Additionally, you may evaluate how the addition of Arvinas to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Bonds Directory
Find actively traded corporate debentures issued by US companies
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Is Arvinas' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arvinas. If investors know Arvinas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arvinas listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.62)
Revenue Per Share
1.414
Quarterly Revenue Growth
0.042
Return On Assets
(0.20)
Return On Equity
(0.60)
The market value of Arvinas is measured differently than its book value, which is the value of Arvinas that is recorded on the company's balance sheet. Investors also form their own opinion of Arvinas' value that differs from its market value or its book value, called intrinsic value, which is Arvinas' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arvinas' market value can be influenced by many factors that don't directly affect Arvinas' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arvinas' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arvinas is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arvinas' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.